Maria was trained as a bioengineer at the Université Catholique de Louvain (UCL) and did her Ph.D. in bacterial metabolism in the department of biochemistry, at the University of Oxford in 1990.  When she came to the de Duve Institute as a young postdoc to join the lab of Emile Van Schaftingen, she discovered and become passionate about the world of intermediate metabolism. She obtained a tenured position in 2000 (Chercheur Qualifié of the FNRS). She has collaborated with Emile on many projects, including the discovery of the mechanism of neutropenia in glycogen storage disease type 1b and of two other inborn errors of metabolite repair: the L-2-hydroxyglutaric aciduria and the deficiency in Nit1. Lately they established PGM2L1-deficiency as a new neurodevelopmental disorder.
Since Emile became an Emeritus professor in 2019, she has her own lab where she continues to develop her projects.

Publications:

Boulanger, C., Stephenne, X., Diederich, J., Mounkoro, P., Chevalier, N., Ferster, A., Van Schaftingen, E., and Veiga-da-Cunha, M. (2022). Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5. J Inherit Metab Dis 45, 759-768.

Caligiore, F., Zangelmi, E., Vetro, C., Kentache, T., Dewulf, J.P., Veiga-da-Cunha, M., Van Schaftingen, E., Bommer, G., and Peracchi, A. (2022). Human cytosolic transaminases: side activities and patterns of discrimination towards physiologically available alternative substrates. Cell Mol Life Sci 79, 421.

Makrilakis, K., Barmpagianni, A., and Veiga-da-Cunha, M. (2022). Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report. Cureus 14, e27264.

Fogh, S., Dipace, G., Bie, A., Veiga-da-Cunha, M., Hansen, J., Kjeldsen, M., Mosegaard, S., Ribes, A., Gregersen, N., Aagaard, L., Van Schaftingen, E., and Olsen, R.K.J. (2021). Variants in the ethylmalonyl-CoA decarboxylase (ECHDC1) gene: a novel player in ethylmalonic aciduria? J Inherit Metab Dis 44, 1215-1225.

Fusaro, M., Vincent, A., Castelle, M., Rosain, J., Fournier, B., Veiga-da-Cunha, M., Kentache, T., Serre, J., Fallet-Bianco, C., Delezoide, A.L., Renesme, L., Picard, F.M., Lasseaux, E., Aladjidi, N., Seta, N., Cormier-Daire, V., Schaftingen, E.V., Neven, B., Moshous, D., Blesson, S., and Picard, C. (2021). Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations. J Clin Immunol 41, 958-966.

Kentache, T., Thabault, L., Deumer, G., Haufroid, V., Frederick, R., Linster, C.L., Peracchi, A., Veiga-da-Cunha, M., Bommer, G.T., and Van Schaftingen, E. (2021). The metalloprotein YhcH is an anomerase providing N-acetylneuraminate aldolase with the open form of its substrate. J Biol Chem 296, 100699.

Morava, E., Schatz, U.A., Torring, P.M., Abbott, M.A., Baumann, M., Brasch-Andersen, C., Chevalier, N., Dunkhase-Heinl, U., Fleger, M., Haack, T.B., Nelson, S., Potelle, S., Radenkovic, S., Bommer, G.T., Van Schaftingen, E., and Veiga-da-Cunha, M. (2021). Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorder. Am J Hum Genet 108, 1151-1160.

Resaz, R., Raggi, F., Segalerba, D., Lavarello, C., Gamberucci, A., Bosco, M.C., Astigiano, S., Assunto, A., Melis, D., D'Acierno, M., Veiga-da-Cunha, M., Petretto, A., Marcolongo, P., Trepiccione, F., and Eva, A. (2021). The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb. Mol Genet Metab Rep 29, 100813.

Rossi, A., Miele, E., Fecarotta, S., Veiga-da-Cunha, M., Martinelli, M., Mollica, C., D'Armiento, M., Mozzillo, E., Strisciuglio, P., Derks, T.G.J., Staiano, A., and Parenti, G. (2021). Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report. Ital J Pediatr 47, 149.

Bommer, G.T., Van Schaftingen, E., and Veiga-da-Cunha, M. (2020). Metabolite Repair Enzymes Control Metabolic Damage in Glycolysis. Trends Biochem Sci 45, 228-243.

Veiga-da-Cunha, M., Van Schaftingen, E., and Bommer, G.T. (2020). Inborn errors of metabolite repair. J Inherit Metab Dis 43, 14-24.

Wortmann, S.B., Van Hove, J.L.K., Derks, T.G.J., Chevalier, N., Knight, V., Koller, A., Oussoren, E., Mayr, J.A., van Spronsen, F.J., Lagler, F.B., Gaughan, S., Van Schaftingen, E., and Veiga-da-Cunha, M. (2020). Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood 136, 1033-1043.

Zangelmi, E., Ronda, L., Castagna, C., Campanini, B., Veiga-da-Cunha, M., Van Schaftingen, E., and Peracchi, A. (2020). Off to a slow start: Analyzing lag phases and accelerating rates in steady-state enzyme kinetics. Anal Biochem 593, 113595.

Dewulf, J.P., Gerin, I., Rider, M.H., Veiga-da-Cunha, M., Van Schaftingen, E., and Bommer, G.T. (2019). The synthesis of branched-chain fatty acids is limited by enzymatic decarboxylation of ethyl- and methylmalonyl-CoA. Biochem J 476, 2427-2447.

Veiga-da-Cunha, M., Chevalier, N., Stephenne, X., Defour, J.P., Paczia, N., Ferster, A., Achouri, Y., Dewulf, J.P., Linster, C.L., Bommer, G.T., and Van Schaftingen, E. (2019). Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A 116, 1241-1250.

Dumitru, A.C., Conrard, L., Lo Giudice, C., Henriet, P., Veiga-da-Cunha, M., Derclaye, S., Tyteca, D., and Alsteens, D. (2018). High-resolution mapping and recognition of lipid domains using AFM with toxin-derivatized probes. Chem Commun (Camb) 54, 6903-6906.

Kwiatkowski, S., Seliga, A.K., Vertommen, D., Terreri, M., Ishikawa, T., Grabowska, I., Tiebe, M., Teleman, A.A., Jagielski, A.K., Veiga-da-Cunha, M., and Drozak, J. (2018). SETD3 protein is the actin-specific histidine N-methyltransferase. Elife 7.

Peracchi, A., Veiga-da-Cunha, M., Kuhara, T., Ellens, K.W., Paczia, N., Stroobant, V., Seliga, A.K., Marlaire, S., Jaisson, S., Bommer, G.T., Sun, J., Huebner, K., Linster, C.L., Cooper, A.J.L., and Van Schaftingen, E. (2017). Nit1 is a metabolite repair enzyme that hydrolyzes deaminated glutathione. Proc Natl Acad Sci U S A 114, E3233-E3242.

Blancquaert, L., Baba, S.P., Kwiatkowski, S., Stautemas, J., Stegen, S., Barbaresi, S., Chung, W., Boakye, A.A., Hoetker, J.D., Bhatnagar, A., Delanghe, J., Vanheel, B., Veiga-da-Cunha, M., Derave, W., and Everaert, I. (2016). Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by beta-alanine transamination. J Physiol 594, 4849-4863.

Collard, F., Baldin, F., Gerin, I., Bolsee, J., Noel, G., Graff, J., Veiga-da-Cunha, M., Stroobant, V., Vertommen, D., Houddane, A., Rider, M.H., Linster, C.L., Van Schaftingen, E., and Bommer, G.T. (2016). A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast. Nat Chem Biol 12, 601-607.

Carquin, M., Conrard, L., Pollet, H., Van Der Smissen, P., Cominelli, A., Veiga-da-Cunha, M., Courtoy, P.J., and Tyteca, D. (2015). Cholesterol segregates into submicrometric domains at the living erythrocyte membrane: evidence and regulation. Cell Mol Life Sci 72, 4633-4651.

Rzem, R., Achouri, Y., Marbaix, E., Schakman, O., Wiame, E., Marie, S., Gailly, P., Vincent, M.F., Veiga-da-Cunha, M., and Van Schaftingen, E. (2015). A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair. PLoS One 10, e0119540.

Van Schaftingen, E., Veiga-da-Cunha, M., and Linster, C.L. (2015). Enzyme complexity in intermediary metabolism. J Inherit Metab Dis 38, 721-727.

Carquin, M., Pollet, H., Veiga-da-Cunha, M., Cominelli, A., Van Der Smissen, P., N'Kuli, F., Emonard, H., Henriet, P., Mizuno, H., Courtoy, P.J., and Tyteca, D. (2014). Endogenous sphingomyelin segregates into submicrometric domains in the living erythrocyte membrane. J Lipid Res 55, 1331-1342.

Drozak, J., Veiga-da-Cunha, M., Kadziolka, B., and Van Schaftingen, E. (2014). Vertebrate Acyl CoA synthetase family member 4 (ACSF4-U26) is a beta-alanine-activating enzyme homologous to bacterial non-ribosomal peptide synthetase. FEBS J 281, 1585-1597.

Marlaire, S., Van Schaftingen, E., and Veiga-da-Cunha, M. (2014). C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA. J Inherit Metab Dis 37, 13-19.

Veiga-da-Cunha, M., Chevalier, N., Stroobant, V., Vertommen, D., and Van Schaftingen, E. (2014). Metabolite proofreading in carnosine and homocarnosine synthesis: molecular identification of PM20D2 as beta-alanyl-lysine dipeptidase. J Biol Chem 289, 19726-19736.

Van Schaftingen, E., Rzem, R., Marbaix, A., Collard, F., Veiga-da-Cunha, M., and Linster, C.L. (2013). Metabolite proofreading, a neglected aspect of intermediary metabolism. J Inherit Metab Dis 36, 427-434.

Veiga-da-Cunha, M., Verhoeven-Duif, N.M., de Koning, T.J., Duran, M., Dorland, B., and Van Schaftingen, E. (2013). Mutations in the AGXT2L2 gene cause phosphohydroxylysinuria. J Inherit Metab Dis 36, 961-966.

Van Schaftingen, E., Collard, F., Wiame, E., and Veiga-da-Cunha, M. (2012). Enzymatic repair of Amadori products. Amino Acids 42, 1143-1150.

Veiga-da-Cunha, M., Hadi, F., Balligand, T., Stroobant, V., and Van Schaftingen, E. (2012). Molecular identification of hydroxylysine kinase and of ammoniophospholyases acting on 5-phosphohydroxy-L-lysine and phosphoethanolamine. J Biol Chem 287, 7246-7255.

Linster, C.L., Noel, G., Stroobant, V., Vertommen, D., Vincent, M.F., Bommer, G.T., Veiga-da-Cunha, M., and Van Schaftingen, E. (2011). Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading. J Biol Chem 286, 42992-43003.

Drozak, J., Veiga-da-Cunha, M., Vertommen, D., Stroobant, V., and Van Schaftingen, E. (2010). Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). J Biol Chem 285, 9346-9356.

Pascal, S.M., Veiga-da-Cunha, M., Gilon, P., Van Schaftingen, E., and Jonas, J.C. (2010). Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations. Am J Physiol Endocrinol Metab 298, E586-596.

Veiga-da-Cunha, M., Tyteca, D., Stroobant, V., Courtoy, P.J., Opperdoes, F.R., and Van Schaftingen, E. (2010). Molecular identification of NAT8 as the enzyme that acetylates cysteine S-conjugates to mercapturic acids. J Biol Chem 285, 18888-18898.

Jaisson, S., Veiga-da-Cunha, M., and Van Schaftingen, E. (2009). Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. Biochimie 91, 1066-1071.

Van Schaftingen, E., Rzem, R., and Veiga-da-Cunha, M. (2009). L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis 32, 135-142.

Veiga-da-Cunha, M., Sokolova, T., Opperdoes, F., and Van Schaftingen, E. (2009). Evolution of vertebrate glucokinase regulatory protein from a bacterial N-acetylmuramate 6-phosphate etherase. Biochem J 423, 323-332.

Kardon, T., Stroobant, V., Veiga-da-Cunha, M., and Schaftingen, E.V. (2008). Characterization of mammalian sedoheptulokinase and mechanism of formation of erythritol in sedoheptulokinase deficiency. FEBS Lett 582, 3330-3334.

Veiga-da-Cunha, M., Vleugels, W., Maliekal, P., Matthijs, G., and Van Schaftingen, E. (2008). Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase. J Biol Chem 283, 33988-33993.

Gemayel, R., Fortpied, J., Rzem, R., Vertommen, D., Veiga-da-Cunha, M., and Van Schaftingen, E. (2007). Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation. FEBS J 274, 4360-4374.

Maliekal, P., Sokolova, T., Vertommen, D., Veiga-da-Cunha, M., and Van Schaftingen, E. (2007). Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family. J Biol Chem 282, 31844-31851.

Rzem, R., Vincent, M.F., Van Schaftingen, E., and Veiga-da-Cunha, M. (2007). L-2-hydroxyglutaric aciduria, a defect of metabolite repair. J Inherit Metab Dis 30, 681-689.

Van Schaftingen, E., Delpierre, G., Collard, F., Fortpied, J., Gemayel, R., Wiame, E., and Veiga-da-Cunha, M. (2007). Fructosamine 3-kinase and other enzymes involved in protein deglycation. Adv Enzyme Regul 47, 261-269.

Delpierre, G., Veiga-da-Cunha, M., Vertommen, D., Buysschaert, M., and Van Schaftingen, E. (2006). Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab 32, 31-39.

Rzem, R., Van Schaftingen, E., and Veiga-da-Cunha, M. (2006). The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. Biochimie 88, 113-116.

Veiga da-Cunha, M., Jacquemin, P., Delpierre, G., Godfraind, C., Theate, I., Vertommen, D., Clotman, F., Lemaigre, F., Devuyst, O., and Van Schaftingen, E. (2006). Increased protein glycation in fructosamine 3-kinase-deficient mice. Biochem J 399, 257-264.

Barriere, C., Veiga-da-Cunha, M., Pons, N., Guedon, E., van Hijum, S.A., Kok, J., Kuipers, O.P., Ehrlich, D.S., and Renault, P. (2005). Fructose utilization in Lactococcus lactis as a model for low-GC gram-positive bacteria: its regulator, signal, and DNA-binding site. J Bacteriol 187, 3752-3761.

Gloyn, A.L., Odili, S., Zelent, D., Buettger, C., Castleden, H.A., Steele, A.M., Stride, A., Shiota, C., Magnuson, M.A., Lorini, R., d'Annunzio, G., Stanley, C.A., Kwagh, J., van Schaftingen, E., Veiga-da-Cunha, M., Barbetti, F., Dunten, P., Han, Y., Grimsby, J., Taub, R., Ellard, S., Hattersley, A.T., and Matschinsky, F.M. (2005). Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem 280, 14105-14113.

Achouri, Y., Noel, G., Vertommen, D., Rider, M.H., Veiga-Da-Cunha, M., and Van Schaftingen, E. (2004). Identification of a dehydrogenase acting on D-2-hydroxyglutarate. Biochem J 381, 35-42.

Rzem, R., Veiga-da-Cunha, M., Noel, G., Goffette, S., Nassogne, M.C., Tabarki, B., Scholler, C., Marquardt, T., Vikkula, M., and Van Schaftingen, E. (2004). A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101, 16849-16854.

Smal, C., Bertrand, L., Van den Neste, E., Cardoen, S., Veiga-da-Cunha, M., Marie, S., Race, V., Ferrant, A., Van den Berghe, G., and Bontemps, F. (2004). New evidences for a regulation of deoxycytidine kinase activity by reversible phosphorylation. Nucleosides Nucleotides Nucleic Acids 23, 1363-1365.

Veiga-da-Cunha, M., Collet, J.F., Prieur, B., Jaeken, J., Peeraer, Y., Rabbijns, A., and Van Schaftingen, E. (2004). Mutations responsible for 3-phosphoserine phosphatase deficiency. Eur J Hum Genet 12, 163-166.

Veiga-da-Cunha, M., Delplanque, J., Gillain, A., Bonthron, D.T., Boutin, P., Van Schaftingen, E., and Froguel, P. (2003). Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians. Diabetologia 46, 704-711.

Veiga-da-Cunha, M., and Van Schaftingen, E. (2002). Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase. J Biol Chem 277, 8466-8473.

Moukil, M.A., Veiga-da-Cunha, M., and Van Schaftingen, E. (2000). Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose. Diabetes 49, 195-201.

Veiga-da-Cunha, M., Gerin, I., and Van Schaftingen, E. (2000a). How many forms of glycogen storage disease type I? Eur J Pediatr 159, 314-318.

Veiga-da-Cunha, M., Hoyoux, A., and Van Schaftingen, E. (2000b). Overexpression and purification of fructose-1-phosphate kinase from Escherichia coli: application to the assay of fructose 1-phosphate. Protein Expr Purif 19, 48-52.

Weston, B.W., Lin, J.L., Muenzer, J., Cameron, H.S., Arnold, R.R., Seydewitz, H.H., Mayatepek, E., Van Schaftingen, E., Veiga-da-Cunha, M., Matern, D., and Chen, Y.T. (2000). Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr Res 48, 329-334.

Collard, F., Collet, J.F., Gerin, I., Veiga-da-Cunha, M., and Van Schaftingen, E. (1999). Identification of the cDNA encoding human 6-phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway(1). FEBS Lett 459, 223-226.

de la Iglesia, N., Veiga-da-Cunha, M., Van Schaftingen, E., Guinovart, J.J., and Ferrer, J.C. (1999). Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett 456, 332-338.

Follens, A., Veiga-da-Cunha, M., Merckx, R., van Schaftingen, E., and van Eldere, J. (1999). acs1 of Haemophilus influenzae type a capsulation locus region II encodes a bifunctional ribulose 5-phosphate reductase- CDP-ribitol pyrophosphorylase. J Bacteriol 181, 2001-2007.

Gerin, I., Veiga-da-Cunha, M., Noel, G., and Van Schaftingen, E. (1999). Structure of the gene mutated in glycogen storage disease type Ib. Gene 227, 189-195.

Veiga-da-Cunha, M., Gerin, I., Chen, Y.T., Lee, P.J., Leonard, J.V., Maire, I., Wendel, U., Vikkula, M., and Van Schaftingen, E. (1999). The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet 7, 717-723.

Veiga-da-Cunha, M., Gerin, I., Chen, Y.T., de Barsy, T., de Lonlay, P., Dionisi-Vici, C., Fenske, C.D., Lee, P.J., Leonard, J.V., Maire, I., McConkie-Rosell, A., Schweitzer, S., Vikkula, M., and Van Schaftingen, E. (1998). A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet 63, 976-983.

Collet, J.F., Gerin, I., Rider, M.H., Veiga-da-Cunha, M., and Van Schaftingen, E. (1997). Human L-3-phosphoserine phosphatase: sequence, expression and evidence for a phosphoenzyme intermediate. FEBS Lett 408, 281-284.

Gerin, I., Veiga-da-Cunha, M., Achouri, Y., Collet, J.F., and Van Schaftingen, E. (1997). Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett 419, 235-238.

Matthijs, G., Schollen, E., Pardon, E., Veiga-Da-Cunha, M., Jaeken, J., Cassiman, J.J., and Van Schaftingen, E. (1997). Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 16, 88-92.

Miranda, M., Ramos, A., Veiga-da-Cunha, M., Loureiro-Dias, M.C., and Santos, H. (1997). Biochemical basis for glucose-induced inhibition of malolactic fermentation in Leuconostoc oenos. J Bacteriol 179, 5347-5354.

Niculescu, L., Veiga-da-Cunha, M., and Van Schaftingen, E. (1997). Investigation on the mechanism by which fructose, hexitols and other compounds regulate the translocation of glucokinase in rat hepatocytes. Biochem J 321 ( Pt 1), 239-246.

van Schaftingen, E., Veiga-da-Cunha, M., and Niculescu, L. (1997). The regulatory protein of glucokinase. Biochem Soc Trans 25, 136-140.

Niculescu, L., Veiga-da-Cunha, M., and Van Schaftingen, E. (1996). Enzymatic assays of fructose-1-phosphate and fructose-1,6-bisphosphate in the picomole range. Anal Biochem 235, 243-244.

Veiga-da-Cunha, M., Courtois, S., Michel, A., Gosselain, E., and Van Schaftingen, E. (1996a). Amino acid conservation in animal glucokinases. Identification of residues implicated in the interaction with the regulatory protein. J Biol Chem 271, 6292-6297.

Veiga-da-Cunha, M., Xu, L.Z., Lee, Y.H., Marotta, D., Pilkis, S.J., and Van Schaftingen, E. (1996b). Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia 39, 1173-1179.

Van Schaftingen, E., Detheux, M., and Veiga da Cunha, M. (1994). Short-term control of glucokinase activity: role of a regulatory protein. FASEB J 8, 414-419.

Veiga-Da-Cunha, M., Detheux, M., Watelet, N., and Van Schaftingen, E. (1994). Cloning and expression of a Xenopus liver cDNA encoding a fructose-phosphate-insensitive regulatory protein of glucokinase. Eur J Biochem 225, 43-51.

Veiga-da-Cunha, M., Santos, H., and Van Schaftingen, E. (1993). Pathway and regulation of erythritol formation in Leuconostoc oenos. J Bacteriol 175, 3941-3948.

Veiga da Cunha, M., and Foster, M.A. (1992). Sugar-glycerol cofermentations in lactobacilli: the fate of lactate. J Bacteriol 174, 1013-1019.

Veiga-Da-Cunha, M., Firme, P., Romao, M.V., and Santos, H. (1992). Application of C Nuclear Magnetic Resonance To Elucidate the Unexpected Biosynthesis of Erythritol by Leuconostoc oenos. Appl Environ Microbiol 58, 2271-2279.

Veiga-da-Cunha, M., and Foster, M.A. (1992). 1,3-Propanediol:NAD+ oxidoreductases of Lactobacillus brevis and Lactobacillus buchneri. Appl Environ Microbiol 58, 2005-20